Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raloxifene vs Hormone Therapy in Postmenopausal Schizophrenia
NCT00206557Phase 2Completed
- Sponsor
- Alfred Health
- Start
- Oct 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of raloxifene in schizophrenia, sponsored by Alfred Health. Started Oct 2002; status: completed.
02
Drugs
raloxifene
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00206557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00206557.